TY  - JOUR
AU  - Ortega-Paz, Luis
AU  - Cristóbal, Helena
AU  - Ortiz-Perez, José Tomás
AU  - García de Frutos, Pablo
AU  - Mendieta, Guiomar
AU  - Sandoval, Elena
AU  - Rodriguez, Juan José
AU  - Ortega, Emilio
AU  - García-Álvarez, Ana
AU  - Brugaletta, Salvatore
AU  - Sabaté, Manel
AU  - Dantas, Ana Paula
PY  - 2023
DO  - 10.1002/ehf2.14186
UR  - http://hdl.handle.net/20.500.12105/16854
AB  - AIMSInhibitors of SGLT2 (SGLT2i) have shown a positive impact in patients with chronic heart failure and reduced ejection fraction (HFrEF). Nonetheless, the direct effects of SGLT2i on cardiac cells and how their association with main drugs used for...
LA  - eng
PB  - Wiley
KW  - Heart Failure
KW  - Humans
KW  - Spironolactone
KW  - Matrix Metalloproteinase 9
KW  - Sodium-Glucose Transporter 2
KW  - Stroke Volume
KW  - Glycogen Synthase Kinase 3
KW  - Interleukin-6
KW  - Proto-Oncogene Proteins c-akt
KW  - Valsartan
KW  - Fibroblasts
KW  - Biomarkers
TI  - Direct actions of dapagliflozin and interactions with LCZ696 and spironolactone on cardiac fibroblasts of patients with heart failure and reduced ejection fraction.
TY  - journal article
ER  -